and we subsequently validated its utility in predicting the likelihood of NAFLD in healthy controls and insulin-resistant individuals with obesity using proton magnetic resonance spectroscopy (1H-MRS) [16,17]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.